E-LIB Suche - Ergebnisse für: Wierzbicki, A.S.

1

Physica status solidi

Volume 65, Number 2: October 1 Physica status solidi ; Volume 65, Number 2, B

Aleshin, V. G ; Alizon, J ; Ascher, E... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

2

Familial Chylomicronaemia Syndrome (FCS) Score Validation i..:

Bashir, B. ; Kwok, S. ; Wierzbicki, A.S....
Atherosclerosis Plus. 54 (2023) - p. S8 , 2023

Link: https://doi.org/10.1016/..

3

Familial Chylomicronaemia Syndrome (FCS) Compared to Multif..:

Bashir, B. ; Kwok, S. ; Wierzbicki, A.S....
Atherosclerosis Plus. 54 (2023) - p. S4 , 2023

Link: https://doi.org/10.1016/..

4

Experimental investigation of angle length effect – angles ..:

, In: Modern Trends in Research on Steel, Aluminium and Composite Structures,

Barcewicz, W. ; Wierzbicki, S. ; Giżejowski, M.A... - p. 85-91 , 2021

Link: https://doi.org/10.1201/..

5

Acute kidney injury: prevention, detection, and management...:

Barrett, T. ; Khwaja, A. ; Carmona, C....
Clinical Radiology. 76 (2021) 3 - p. 193-199 , 2021

Link: https://doi.org/10.1016/..

6

Familial chylomicronaemia syndrome: National genetics testi..:

Newmark, J. ; Bell, C. ; O'Sullivan, D....
Atherosclerosis. 315 (2020) - p. e44 , 2020

Link: https://doi.org/10.1016/..

7

Further options for treating lipids in people with diabetes..:

Wierzbicki, A. S.
Diabetic Medicine. 35 (2018) 9 - p. 1173-1180 , 2018

Link: https://doi.org/10.1111/..

8

An audit of the effectiveness of PCSK9 inhibition in reduci..:

Kohli, M. ; McMahon, Z. ; Ramachandran, R....
Atherosclerosis Supplements. 28 (2017) - p. e11 , 2017

Link: https://doi.org/10.1016/..

9

The impact of lipoprotein lipase deficiency on quality of l..:

Neelamekam, S. ; Kwok, S. ; Malone, R...
Atherosclerosis Supplements. 28 (2017) - p. e17 , 2017

Link: https://doi.org/10.1016/..

10

Familial Hypercholesterolaemia in the Era of Genetic Testin:

Hughes, D. P. ; Viljoen, A. ; Wierzbicki, A. S.
Current Cardiology Reports. 18 (2016) 5 - p. , 2016

Link: https://doi.org/10.1007/..

11

The Ebbs and Flows in the Development of Cholesterol-Loweri..:

Hajhosseiny, R ; Sabir, I ; Khavandi, K.
Clinical Pharmacology & Therapeutics. 96 (2014) 1 - p. 64-73 , 2014

Link: https://doi.org/10.1038/..

12

Corrigendum to "Association of bone turnover markers and ar..:

Manghat, P. ; Souleimanova, I. ; Cheung, J....
Bone. 53 (2013) 1 - p. 319 , 2013

Link: https://doi.org/10.1016/..

13

U.K. consensus statement on safe clinical prescribing of be..:

Scarisbrick, J.J. ; Morris, S. ; Azurdia, R....
British Journal of Dermatology. 168 (2012) 1 - p. 192-200 , 2012

Link: https://doi.org/10.1111/..

14

(2) The role of improved phenotypic confirmation of familia..:

Clarke, R.E.J. ; MacMahon, Z. ; Padayachee, T.S....
Atherosclerosis. 223 (2012) 2 - p. 528 , 2012

Link: https://doi.org/10.1016/..

15

Association of bone turnover markers and arterial stiffness..:

Manghat, P. ; Souleimanova, I. ; Cheung, J....
Bone. 48 (2011) 5 - p. 1127-1132 , 2011

Link: https://doi.org/10.1016/..